These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8495499)
1. Proliferation and functional responses of bone marrow-derived mast cells after activation. Levi-Schaffer F; Shalit M Cell Immunol; 1993 May; 148(2):435-43. PubMed ID: 8495499 [TBL] [Abstract][Full Text] [Related]
2. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone. Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578 [TBL] [Abstract][Full Text] [Related]
3. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814 [TBL] [Abstract][Full Text] [Related]
4. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. Robin JL; Seldin DC; Austen KF; Lewis RA J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947 [TBL] [Abstract][Full Text] [Related]
5. Unresponsiveness of rat peritoneal mast cells to immunologic reactivation. Levi-Schaffer F; Gare M; Shalit M J Immunol; 1990 Nov; 145(10):3418-24. PubMed ID: 1700010 [TBL] [Abstract][Full Text] [Related]
6. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. Katz HR; Raizman MB; Gartner CS; Scott HC; Benson AC; Austen KF J Immunol; 1992 Feb; 148(3):868-71. PubMed ID: 1309842 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype. Stevens RL; Bloes WF; Seldin DC; Razin E; Katz HR; Austen KF J Immunol; 1984 Nov; 133(5):2674-80. PubMed ID: 6332858 [TBL] [Abstract][Full Text] [Related]
8. [The culture of mouse bone marrow-derived mast cells (BMMC) and the anaphylactic release of chemical mediators]. Yamamura H; Ohkawa E; Kohno S; Ohata K Arerugi; 1992 Sep; 41(9):1367-79. PubMed ID: 1280088 [TBL] [Abstract][Full Text] [Related]
9. Strain difference of murine bone marrow-derived mast cell functions. Noguchi J; Kuroda E; Yamashita U J Leukoc Biol; 2005 Sep; 78(3):605-11. PubMed ID: 16126842 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin D2 generation in mouse bone marrow-derived mast cells exposed to dexamethasone is associated with endogenous peroxidase activity. Michel L; Pitton C; Prost C; Massé JM; Mencia-Huerta JM; Burtin C; Maclouf J; Breton-Gorius J; Benveniste J; Dubertret L Lab Invest; 1988 Nov; 59(5):613-24. PubMed ID: 2460694 [TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced degranulation of cultured bone marrow-derived mast cells: effect on calcium uptake. Pervin R; Kanner BI; Marx G; Razin E Immunology; 1985 Dec; 56(4):667-72. PubMed ID: 2416681 [TBL] [Abstract][Full Text] [Related]
13. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils. Saito H; Okajima F; Molski TF; Sha'afi RI; Ui M; Ishizaka T J Immunol; 1987 Jun; 138(11):3927-34. PubMed ID: 2438330 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin. Katz HR; Levine JS; Austen KF J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells. Dayton ET; Caulfield JP; Hein A; Austen KF; Stevens RL J Immunol; 1989 Jun; 142(12):4307-13. PubMed ID: 2786027 [TBL] [Abstract][Full Text] [Related]
16. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells. DuBuske L; Austen KF; Czop J; Stevens RL J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085 [TBL] [Abstract][Full Text] [Related]
17. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and morphological modifications in dexamethasone-treated mouse bone marrow-derived mast cells. Pitton C; Michel L; Salem P; Benhamou M; Mencia-Huerta JM; Maclouf J; Prost C; Burtin C; Dubertret L; Benveniste J J Immunol; 1988 Oct; 141(7):2437-44. PubMed ID: 2459209 [TBL] [Abstract][Full Text] [Related]
19. The stimuli releasing histamine from murine bone marrow-derived mast cells (BMMC). 3. Effect of coculture with 3T3 fibroblasts on the histamine releasability of BMMC. Sakaguchi N; Saito H; Iikura Y Arerugi; 1992 Apr; 41(4):519-25. PubMed ID: 1377904 [TBL] [Abstract][Full Text] [Related]